Envista appoints Eric Hammes as CFO, Stefan Nilsson and Veronica Acurio to lead Nobel Biocare and Ormco

Envista Holdings Corp

Eric Hammes appointed CFO effective August 8, 2024; interim CFO Stephen Keller returns to lead investor relations.
Hammes compensation: base salary $575k, target bonus 75% of salary, LTI $1.2M, one-time cash $1.02M, RSUs $1.2M.
Stefan Nilsson named President of Nobel Biocare, effective July 15; previously CEO of Colosseum Dental Group.
Veronica Acurio named President of Orthodontics (Ormco), effective August 2; formerly President of 3M Medical Solutions Division.
CEO Paul Keel cites relevant dental and healthcare experience; appointments expand leadership team.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Eric Hammes

Senior Vice President and Chief Financial Officer

NVST · Envista Holdings Corp

Effective: 2024-08-08
Filed: July 15, 2024, 7:59 PM ET

On July 15, 2024, Envista Holdings Corporation (the “Company”) announced that it has appointed Eric Hammes as the Senior Vice President and Chief Financial Officer of the Company, with such appointment to be effective as of August 8, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Hammes was appointed as Senior Vice President and Chief Financial Officer at Envista Holdings Corp.

Action: appointed
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

On July 15, 2024, Envista Holdings Corporation (the “Company”) announced that it has appointed Eric Hammes as the Senior Vice President and Chief Financial Officer of the Company, with such appointment to be effective as of August 8, 2024.

View on SEC.gov

Envista Holdings Corp filing history →

Source: SEC EDGAR

accession 0001757073-24-000063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.